C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
11/2011
11/24/2011	US20110287012 Nucleic acid encoding cytokine receptor zcytor17
11/24/2011	US20110287011 DDR1-Binding Agents and Methods of Use Thereof
11/24/2011	US20110287010 Diagnostic methods and markers
11/24/2011	US20110287005 Monoclonal antibodies against amyloid beta protein and uses thereof
11/24/2011	US20110287002 Antibodies against epidermal growth factor receptor (egfr) and uses thereof
11/24/2011	US20110287000 Treatment of autoimmune and inflammatory disease
11/24/2011	US20110286977 G6PC2-Encoded Beta Cell Surface Tags
11/24/2011	US20110286963 Human soluble cd146, preparation and uses thereof
11/24/2011	US20110286958 Hpma polymer platinum chelates
11/24/2011	US20110286924 Novel human endogenous retroviral erv3 variant and uses thereof in the diagnosing ovarian cancer
11/24/2011	US20110286918 Immunotherapy of autoimmune disorders using antibodies which target b-cells
11/24/2011	US20110286916 Generation and characterization of anti-notch antibodies for therapeutic and diagnostic use
11/24/2011	CA2799746A1 Rapid isolation of monoclonal antibodies from animals
11/24/2011	CA2799633A1 Improved anti-serum albumin binding variants
11/24/2011	CA2798778A1 Anti-human trop-2 antibody having anti-tumor activity in vivo
11/24/2011	CA2791951A1 Biological materials related to her3
11/23/2011	EP2388593A2 Method for in vitro diagnosis of PVL-producing Staphylococcus aureus
11/23/2011	EP2388323A2 Humanized anti-9 integrin antibodies and the uses thereof
11/23/2011	EP2388320A1 Anti-hs6st2 antibody and use thereof
11/23/2011	EP2388277A2 Human anti-B7RP1 neutralizing antibodies
11/23/2011	EP2388276A2 Human anti-B7RP1 neutralizing antibodies
11/23/2011	EP2388275A2 An aglycosylated IgG1 antibody to CD3
11/23/2011	EP2388274A1 Methods of purifying anti A Beta antibodies
11/23/2011	EP2388273A1 Antibodies with enhanced antibody-dependent cellular cytoxicity activity, methods of their production and use
11/23/2011	EP2388272A1 Antibodies with enhanced antibody-dependent cellular cytoxicity activity, methods of their production and use
11/23/2011	EP2388271A2 Human Antibodies and Proteins
11/23/2011	EP2388270A2 Modulation of SIRPa - CD47 interaction for increasing human hematopoietic stem cell engraftment and compounds therefor
11/23/2011	EP2388265A1 Compositions and methods for the treatment of immune related diseases
11/23/2011	EP2388015A1 DNA expression vectors and methods of use
11/23/2011	EP2387717A1 Methods of determining patient response by measurement of her-2 expression
11/23/2011	EP2387711A1 Methods of determining patient response by measurement of her-3
11/23/2011	EP2387588A1 Process for engineering polyvalent, polyspecific fusion proteins using uteroglobin as skeleton and so obtained products
11/23/2011	EP2387587A1 Recombinant monovalent antibodies
11/23/2011	EP2387586A2 Antibodies against human epo receptor
11/23/2011	EP2387585A1 Antibody
11/23/2011	EP2387584A1 Combination antibodies for the treatment and prevention of disease caused by bacillus anthracis and related bacteria and their toxins
11/23/2011	EP2387583A1 Pulmonary administration of immunoglobulin single variable domains and constructs thereof
11/23/2011	EP2387415A1 Vaccine compositions
11/23/2011	EP2084181B1 A method and preparations for the diagnosis and therapy of multiple sclerosis and immune demyelinating polyneuropathy
11/23/2011	EP1784426B1 Humanized anti-beta7 antagonists and uses therefor
11/23/2011	EP1720909B1 Anti-abeta antibody
11/23/2011	EP1608683B1 Antibodies directed against hepatitis c virus e1e2 complex and pharmaceutical compositions
11/23/2011	EP1578903B1 Novel methods of constructing libraries comprising displayed and/or expressed members of a diverse family of peptides, polypeptides or proteins and the novel libraries
11/23/2011	EP1511772B1 Method for obtaining anti-idiotype antibodies
11/23/2011	EP1362105B1 Anti-interferon-alpha antibodies
11/23/2011	CN1902229B IL-18 binding proteins
11/23/2011	CN102257388A Monoclonal antibody stro-4
11/23/2011	CN102257141A An expression vector and processes thereof
11/23/2011	CN102257138A Tumor antigen peptide and use thereof
11/23/2011	CN102257010A Anti-idiotype antibody against an antibody against the amyloid beta peptide
11/23/2011	CN102257009A Ligands that have binding specificity for dc-sign
11/23/2011	CN102257008A Antibodies against human angiopoietin 2
11/23/2011	CN102257007A Antibodies that bind to il-18 and methods of purifying the same
11/23/2011	CN102257006A Isolation and purification of antibodies using protein a affinity chromatography
11/23/2011	CN102257005A Viral inactivation during purification of antibodies
11/23/2011	CN102257004A Antibodies that bind to il-12 and methods of purifying the same
11/23/2011	CN102257003A Method for generation of immunoglobulin sequences
11/23/2011	CN102251013A Antibody and antigen for recognizing tumor initiator cell and application thereof
11/23/2011	CN102250911A Soluble B7-H1 quantitative detection kit
11/23/2011	CN102250910A Human soluble B7-DC quantitative detection kit
11/23/2011	CN102250250A Human-mouse chimeric anti-human CD19 antibody Hm2E8b and use thereof
11/23/2011	CN102250249A Anti-VEGF/PDGFR (Vascular Endothelial Growth Factor/Platelet-Derived Growth Factor Receptor) beta double-specificity antibody and application thereof
11/23/2011	CN102250248A Anti-VEGF/ANG2 bispecific antibody, and application thereof
11/23/2011	CN102250247A Bispecific antibody to VEGF/ANG2 and application thereof
11/23/2011	CN102250246A Bispecific antibody to VEGF/PDGFR beta and application thereof
11/23/2011	CN102250245A Bispecific antibody capable of resisting B cell lymphoma and application thereof
11/23/2011	CN102250244A Human prolactin receptor antibody and application thereof
11/23/2011	CN102250243A Antibody to interleukins-15
11/23/2011	CN102250242A Protein specific to pancreatic beta cells in islets of langerhans and applications thereof
11/23/2011	CN102250241A Method for separating IgG from bovine colostrum
11/23/2011	CN102250240A Method for purifying human immunoglobulin from separated component I+III of blood plasma
11/23/2011	CN102250239A Protein capable of combining with vp60 protein of rabbit hemorrhagic disease virus and use thereof
11/23/2011	CN102250237A Enzyme-linked immunosorbent assay method of heavy metal mercury
11/23/2011	CN102250231A Chonorchis sinensis specific PPMP antigens and application thereof
11/23/2011	CN102250214A Polypeptide for resisting rheumatoid arthritis and application of polypeptide in pharmacy
11/23/2011	CN101628940B Monoclonal antibody and application thereof
11/23/2011	CN101550192B Monoclonal antibody K42-D2 of antihuman granzyme K and hybridoma cell line for excreting same
11/23/2011	CN101492505B Specific combined polypeptide for lung cancer, preparation and uses thereof
11/23/2011	CN101134778B Monoclonal antibody of esophagus cancer resistant blood vessel endothelium cell
11/22/2011	US8063188 Anti-myostatin antibodies
11/22/2011	US8063187 Methods and compositions for inhibiting CD32B expressing cells
11/22/2011	US8063186 Antibodies to PRO7436 polypeptides
11/22/2011	US8063183 Ephrin extracellular domain polypeptides for use in diagnosis prevention and treatment of cell proliferative disorders
11/22/2011	US8063182 Human TNF receptor fusion protein
11/22/2011	US8063180 Antibodies directed against prothrombin fragment F1+2, the preparation and use thereof
11/22/2011	US8063022 Methods for preventing formation of inhibitory antibodies in the setting of gene therapy
11/22/2011	US8063016 Retro-inverso peptides derived from interleukin-6
11/22/2011	US8062907 Method to assess the severity of rheumatoid arthritis by measuring anti-CCP and serum amyloid A
11/22/2011	US8062892 Genes, compositions, kits, and methods for identification, assessment, prevention and therapy of cervical cancer
11/22/2011	US8062887 Monoclonal antibody specifically recognizing modification site after translation of p53 and kit for assaying modification site containing the same
11/22/2011	US8062886 Plasmid system for multigene expression
11/22/2011	US8062866 Humanized anti-IL-6 antibodies
11/22/2011	US8062865 Expression control using antibody expression optimisation sequences
11/22/2011	US8062864 Nucleic acids encoding antibodies to IL-6, and recombinant production of anti-IL-6 antibodies
11/22/2011	US8062858 Artificial antibody polypeptides
11/22/2011	US8062640 High affinity human antibodies to PCSK9
11/22/2011	US8062638 Prevention and treatment of diseases associated with blood coagulation
11/22/2011	US8062636 Antibody therapy
11/22/2011	US8062635 Bispecific antibody substituting for functional proteins
11/22/2011	US8062634 Methods of treating cutaneous ulcers and grafts using agonist antibodies to IL-23 receptor

1 ... 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 ... 1494